arrow
M

Manuela Ferracin

irccs azienda ospedaliero - universitaria di bologna
H指数:67
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma

循环miR-22早期预测TACE无应答并靶向WEE1在肝细胞癌中

Cells
IF5.2
2026-04-190
OAAI
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts

致纤维化分子在CRISPR编辑的Emery–Dreifuss肌营养不良成纤维细胞中减少

2025-08-270
OA
Epigenetic age acceleration in hematopoietic stem cell transplantation

造血干细胞移植的表观遗传年龄加速

2024-10-030
OAAI
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
2024-10-011
OAAI
MicroRNA dysregulation in ataxia telangiectasia

共济失调毛细血管扩张症中的MicroRNA失调

2024-08-190
OAAI
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma
2024-08-010
OAAI
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
2024-06-041
OAAI
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
2023-07-179
OAAI